Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 28

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 28
---
    708

    Other current liabilities

    119,070

    104,908

    Total current liabilities

    168,628

    165,223

    Long-term debt

    157,015

    93,107

    Long-term portion of finance lease liability

    17,835

    18,532

    Other long-term liabilities

    46,692

    49,723

    Total liabilities

    390,170

    326,585

    Contingencies (Note 13)

    Shareholders’ equity

    Common shares $0.10 par value; 100,000 shares authorized;   38,486 and 37,165 issued and outstanding as of December 31,   2024 and 2023, respectively

    3,849

    3,717

    Additional paid-in capital

    779,718

    746,450

    Accumulated deficit

    (276,141
    )

    (150,144
    )

    Accumulated other comprehensive loss

    (4,302
    )

    (1,293
    )

    Total shareholders’ equity

    503,124

    598,730

    Total liabilities and shareholders’ equity
     
    $
    893,294

    $
    925,315

The accompanying notes form an integral part of these consolidated financial statements. 

F-4

ORTHOFIX MEDICAL INC. 

Consolidated Statements of Operations and Comprehensive Loss

For the years ended December 31, 2024, 2023, and 2022

    (U.S. Dollars, in thousands, except share and per share data)
     
    2024

    2023

    2022

    Net sales
     
    $
    799,491

    $
    746,641

    $
    460,713

    Cost of sales

    253,606

    260,368

    123,544

    Gross profit

    545,885

    486,273

    337,169

    Sales, general, and administrative

    532,525

    530,395

    308,776

    Research and development

    73,643

    80,231

    49,065

    Acquisition-related